期刊文献+

Peroxiredoxin6在胃癌中的表达及其临床意义 被引量:1

Expression of peroxiredoxin 6 in gastric cancer and its clinical significance
原文传递
导出
摘要 目的明确Peroxiredoxin6(Prx6)在胃癌中的表达及其临床意义。方法选择1992至2000年北京大学临床肿瘤学院、北京大学第一医院及内蒙古医学院的胃癌病例手术切除后的石蜡包埋组织,其中胃癌86例,癌旁形态学正常组织69例,通过查阅病理档案获取其临床病理资料;用组织微阵列和免疫组织化学染色方法检测组织中Prx6蛋白表达水平。结果Prx6以细胞质着色为主,胃癌组织中28例(32.6%)表达阳性;癌旁形态学正常组织中65例(94.2%)表达阳性(P〈0.01)。在53例高中分化胃癌组织中,21例(39.6%)Prx6高表达;在33例低分化胃癌组织中,2例(6.1%)Prx6高表达。Prx6在胃癌组织中的表达与患者的年龄、性别、病变部位、浸润深度、临床分期、血管浸润及肝转移均无明显相关性(均P〉0.05)。结论Prx6在胃癌组织中的表达低于癌旁组织,表达强弱与胃癌组织的分化程度有关。 Objective To elucidate the significance of anti-oxidant protein peroxiredoxin 6 (Prx6) expression in gastric cancer (GC) tissue. Methods Eighty-six GC tissues and 69 para-cancer tissues from surgically resected specimens were included. And the clinico-pathological data were collected by reviewing medical records. Tissue microarray and immunohistochemistry (IHC) were used to detect Prx6 protein expression in tissues. Results Prx6 protein was predominantly expressed in cytoplasm. Its expression rate in GC tissues (32. 6%, n =28) was significantly lower than that in para-cancer normal tissues (94. 2%, n = 65, P 〈 0. 05 ). And its protein overexpression rate in well and moderately-differentiated GC tissues was significantly higher than that in lowly-differentiated ones (39. 6% (21/53) vs 6. 1% (2/33), P 〈0. 05). Prx6 expression in gastric cancer tissues was not significantly related to age and sex of patients, lesion site, depth of invasion, clinical staging, vascular invasion and liver metastasis. Conclusions The level of Prx6 protein is lower in GC tissues than that in normal para-cancer ones. And it is significantly correlated with the differentiation degree of GC.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第34期2433-2435,共3页 National Medical Journal of China
关键词 胃肿瘤 活性氧 PEROXIREDOXIN 6 Stomach neplasms Reactive oxygen species Peroxiredoxin 6
  • 相关文献

参考文献16

  • 1Ouyang X, DeWeese TL, Nelson WG, et al. Loss-of-function of Nkx3. 1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res, 2005, 65:6773-6779.
  • 2Quan c, Cha EJ, Lee HL, et al. Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer. J Urol, 2006, 175: 1512-1516.
  • 3Fujita Y, Nakanishi T, Hiramatsu M, et al. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal sqnamous cell carcinoma. Clin Cancer Res, 2006, 12:6415-6420.
  • 4Kinnula VL, Lehtonen S, Sormunen R, et al. Overexpression of peroxiredoxins I, n, m, V, and VI in malignant mesothelioma. Journal of Pathology, 2002, 196:316-323.
  • 5Karihtala P, Mantyniemi A, Kang SW, et al. Peroxiredoxins in breast carcinoma. Clin Cancer Res, 2003, 9:3418-3424.
  • 6Park CK, Kim JH, Moon MJ, et al. Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression. J Cancer Res Clin Oncol, 2008, 134: 255-262.
  • 7Li DQ, Wang L, Fei F, et al. Identification of breast cancer metastasis- associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics, 2006, 6: 3352-3368.
  • 8Chang XZ, Li DQ, Hou YF, et al. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res. 2007.9 :R76.
  • 9郭瑞芳,臧师竹,张亮,李文梅,胡伏莲,吕有勇.转化生长因子β1及其受体基因过量表达与进展期胃癌分化及临床预后的关系[J].中华医学杂志,2006,86(46):3249-3254. 被引量:9
  • 10张静,丁士刚,钟丽君,林三仁,杨彬,彭嘉柔,娄雅欣.消化性溃疡、胃炎与胃癌患者幽门螺杆菌蛋白质组的差异分析[J].中华医学杂志,2006,86(38):2690-2694. 被引量:23

二级参考文献53

  • 1林三仁,张莉.幽门螺杆菌与胃癌关系的研究进展[J].中华医学杂志,2004,84(14):1210-1211. 被引量:31
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:868
  • 3侯意枫,罗建民,邵志敏.自发性肺高转移人乳腺癌细胞系的建立.In:中国抗癌协会乳腺癌专业委员会,editor.2005上海国际乳腺癌论坛暨第8届全国乳腺癌会议;2005 Sept;上海;2005.p.47.
  • 4Kundu B,Shukla A,Chaba R,et al.The excised heat-shock domain of alphaB crystallin is a folded,proteolytically susceptible trimer with significant surface hydrophobicity and a tendency to self-aggregate upon heating[J].Protein Expr Purif,2004,36 (2):263 -271.
  • 5Webster KA.Serine phosphorylation and suppression of apoptosis by the small heat shock protein alphaB-crystallin[J].Circ Res,2003,92(2):130-132.
  • 6Cicek M,Samant RS,Kinter M,et al.Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfectedMDA-MB-435 cells[J].Clin Exp Metastasis,2004,21 (2):149-157.
  • 7Kamradt MC,Lu M,Werner ME,et al.The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3[J].J Biol Chem,2005,280 (12):11059-11066.
  • 8Takashi M,Sakata T,Ohmura M,et al.Elevated concentrations of the small stress protein HSP27 in rat renal tumors[J].Urol Res,1997,25 (3):173-177.
  • 9Chin D,Boyle GM,Williams RM,et al.Alpha B-crystallin,a new independent marker for poor prognosis in head and neck cancer[J].Laryngoscope,2005,115 (7):1239-1242.
  • 10Gupta S,Knowlton AA.Cytosolic heat shock protein 60,hypoxia,and apoptosis[J].Circulation,2002,106(21):2727-2733.

共引文献31

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部